Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

TSXV:CLAS.H - Post Discussion

View:
Post by Kingofstockst on Apr 21, 2020 9:02pm

Ppl go back

And forth instead of verifying what kaly management has told us about phases they've done and so forth. I was told that most of what they said ain't true all you have to do is research it on fda and that my friends is why no big buyer institution or pharma will touch this and why it's at 1.5 cents...
Comment by Kingofstockst on Apr 21, 2020 9:06pm
Also I'm no basher I'm invested in this stock, I'm really starting to think there's paid pumpers here, the stero thing was just to try and make this company go away and under slowly that's all it backfired not sure why but we shall see what rob the scammer does next
Comment by indaknownewfie on Apr 21, 2020 9:31pm
https://www.accessdata.fda.gov/scripts/opdlisting/oopd/listResult.cfm?StartRow=1&EndRow=25
Comment by Belgiumboy on Apr 22, 2020 7:41am
Good info thanks!!! Indaknow, is there a list with all medicines applying for FDA approval at this moment? Europe (EMA) has such a list, wath about the USA/FDA?
Comment by indaknownewfie on Apr 21, 2020 9:30pm
So you are not doing the research yourself? You were TOLD most they said aint true? Who is telling you this?  Here is the link to FDA . Look at #13  and 14 and open them.  Orphan Drug Status
Comment by Kingofstockst on Apr 21, 2020 9:35pm
It's just things don't add up the time frames the food study that was supposed to be done by now, phase 2 no update like what are they hiding no more confidence in this team which is very unfortunate
Comment by indaknownewfie on Apr 21, 2020 9:50pm
I get the loss of confidence because the huge thing that stands out is there needs to be better communication between company and its shareholders but they do have the Patents and they do have the Orphan Drug Designations and they do have stellar Phase 2 results because they use them to gain the patents. But whoever is saying they are lying a out that are misleading people. Did anyone ever expect ...more  
Comment by Kingofstockst on Apr 21, 2020 10:28pm
I hope your right, but we shall see and good luck indaknow...
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities